Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen

Immunotherapy. 2015;7(3):203-6. doi: 10.2217/imt.15.11.

Authors

Bert Schepens¹, Michael Schotsaert, Xavier Saelens

Affiliation

¹ Department of Medical Protein Research, VIB, 9052, Ghent, Belgium.

PMID: 25804473
DOI: 10.2217/imt.15.11

No abstract available

Keywords: human respiratory syncytial virus; small hydrophobic protein; vaccine.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antibodies, Neutralizing / immunology
Antibody-Dependent Cell Cytotoxicity
Antigens, Viral / immunology*
Humans
Immune Evasion
Infant, Newborn
Macrophages, Alveolar / immunology*
Macrophages, Alveolar / virology
Respiratory Syncytial Virus Infections / prevention & control*
Respiratory Syncytial Virus Vaccines / immunology*
Respiratory Syncytial Viruses / immunology*
Retroviridae Proteins, Oncogenic / immunology*
Virus Replication

Substances

Antibodies, Neutralizing
Antigens, Viral
Respiratory Syncytial Virus Vaccines
Retroviridae Proteins, Oncogenic
small hydrophobic protein, virus